Sign up for our Newsletter
Now published in Cancer Research: a Pancreatic Cancer Action Network study predicting that pancreatic cancer will be the second leading cause of cancer-related death around 2020. Learn more.
MM-398 combined with standard chemotherapy boosts overall survival by nearly 2 months in patients previously treated with gemcitabine. Learn more.
Sixteen grants totaling more than $5.1 million have been awarded to scientists and clinicians across the country this year. Learn more.